Financhill
Buy
68

CAC Quote, Financials, Valuation and Earnings

Last price:
$44.78
Seasonality move :
-0.15%
Day range:
$44.61 - $45.04
52-week range:
$34.53 - $46.80
Dividend yield:
3.75%
P/E ratio:
12.76x
P/S ratio:
2.08x
P/B ratio:
1.12x
Volume:
62.6K
Avg. volume:
78.5K
1-year change:
4.16%
Market cap:
$757.8M
Revenue:
$293.8M
EPS (TTM):
$3.51

CAC Analysts' Consensus Rating

The 3 analysts providing 12-month price projections for Camden National Corp. (Maine) shares anticipate an average target of $47.50, ranging from a low estimate of $44.00 to a high estimate of $53.00. This average target implies a growth of 6.29% compared to the current stock price of $44.78.

Consensus Price Target

$47.50

Highest Price Target

$53.00

Lowest Price Target

$44.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 0 1

Hold 0 0 2

Sell 0 0 0
Consensus -- -- Hold

CAC Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock